SYNTHETIC CD4 PEPTIDE DERIVATIVES THAT INHIBIT HIV INFECTION AND CYTOPATHICITY

被引:164
作者
LIFSON, JD
HWANG, KM
NARA, PL
FRASER, B
PADGETT, M
DUNLOP, NM
EIDEN, LE
机构
[1] NIMH,MOLEC & CELLULAR NEUROBIOL UNIT,BETHESDA,MD 20892
[2] NIMH,CELL BIOL LAB,BETHESDA,MD 20892
[3] US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892
[4] NCI,FREDERICK CANC RES FACIL,FREDERICK,MD 21701
[5] GENELABS INC,DIV MED BIOCHEM,REDWOOD CITY,CA 94063
[6] GENELABS INC,DIV CELLULAR IMMUNOL,REDWOOD CITY,CA 94063
关键词
D O I
10.1126/science.2969619
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:712 / 716
页数:5
相关论文
共 38 条
  • [1] RECEPTOR CONCEPT IN EVOLUTION
    ARIENS, EJ
    BELD, AJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1977, 26 (10) : 913 - 918
  • [2] BARANY G, 1979, PEPTIDES ANAL SYNTHE, V5, P1
  • [3] A SOLUBLE RECOMBINANT POLYPEPTIDE COMPRISING THE AMINO-TERMINAL HALF OF THE EXTRACELLULAR REGION OF THE CD4-MOLECULE CONTAINS AN ACTIVE BINDING-SITE FOR HUMAN IMMUNODEFICIENCY VIRUS
    BERGER, EA
    FUERST, TR
    MOSS, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (07) : 2357 - 2361
  • [4] BIDDISON WE, 1983, J IMMUNOL, V131, P152
  • [5] PEPTIDE STUDIES USING A FAST ATOM BOMBARDMENT HIGH-FIELD MASS-SPECTROMETER AND DATA SYSTEM .4. DISULFIDE-CONTAINING PEPTIDES
    BUKO, AM
    FRASER, BA
    [J]. BIOMEDICAL MASS SPECTROMETRY, 1985, 12 (10): : 577 - 585
  • [6] CLASSON BJ, 1986, P NATL ACAD SCI USA, V83, P4499, DOI 10.1073/pnas.83.12.4499
  • [7] THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS
    DALGLEISH, AG
    BEVERLEY, PCL
    CLAPHAM, PR
    CRAWFORD, DH
    GREAVES, MF
    WEISS, RA
    [J]. NATURE, 1984, 312 (5996) : 763 - 767
  • [8] A SOLUBLE FORM OF CD4 (T4) PROTEIN INHIBITS AIDS VIRUS-INFECTION
    DEEN, KC
    MCDOUGAL, JS
    INACKER, R
    FOLENAWASSERMAN, G
    ARTHOS, J
    ROSENBERG, J
    MADDON, PJ
    AXEL, R
    SWEET, RW
    [J]. NATURE, 1988, 331 (6151) : 82 - 84
  • [9] ENGLEMAN EG, 1983, J IMMUNOL, V130, P2623
  • [10] ENGLEMAN EG, 1981, J EXP MED, V153, P193